Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Drew J. Winston"'
Autor:
Shangxin Yang, Ashrit Multani, Jacob M. Garrigues, Michael S. Oh, Peera Hemarajata, Taylor Burleson, Nicole M. Green, Caspian Oliai, Pryce T. Gaynor, Omer E. Beaird, Drew J. Winston, Christopher S. Seet, Joanna M. Schaenman
Publikováno v:
Microorganisms, Vol 11, Iss 8, p 2096 (2023)
Remdesivir is the first FDA-approved drug for treating severe SARS-CoV-2 infection and targets RNA-dependent RNA polymerase (RdRp) that is required for viral replication. To monitor for the development of mutations that may result in remdesivir resis
Externí odkaz:
https://doaj.org/article/858597d350c442229ddcb2f17af38224
Autor:
Susan Realegeno, Oladunni Adeyiga, Drew J. Winston, Omer E. Beaird, Omai B. Garner, Shangxin Yang
Publikováno v:
IDCases, Vol 26, Iss , Pp e01308- (2021)
A 44-year-old woman undergoing therapy for acute promyelocytic leukemia (APL) developed disseminated tuberculosis. Mycobacterium tuberculosis (TB) was isolated from the blood and sputum. Initial drug susceptibility testing (DST) of the blood isolate
Externí odkaz:
https://doaj.org/article/2b27cd73bc9545f28aa82b363cfe53b1
Autor:
Nina Singh, Meei Li Huang, Raymund R. Razonable, Marilyn M. Wagener, G. Marshall Lyon, Fernanda P. Silveira, Drew J. Winston, Ajit P. Limaye, Keith R. Jerome
Publikováno v:
Transplantation. 105:2427-2434
BACKGROUND Risk factors, virological parameters, and outcomes associated with HHV-6 viremia in high-risk donor CMV-seropositive and recipient CMV-seronegative (D+R-) liver transplant recipients in the current era are incompletely defined. METHODS The
Autor:
Nina Singh, Raymund R. Razonable, Marilyn M. Wagener, G. Marshall Lyon, Fernanda P. Silveira, Drew J. Winston, Ajit P. Limaye
Publikováno v:
Clin Infect Dis
Background The relative costs of preemptive therapy (PET) or prophylaxis for the prevention of cytomegalovirus (CMV) disease in high-risk donor CMV-seropositive/recipient-seronegative (D+/R−) liver transplant recipients have not been assessed in th
Autor:
Robert McMillan, Lisa Quach, Joseph DiNorcia, Douglas G. Farmer, Ronald W. Busuttil, Alfonso Molina, Arpit Amin, Drew J. Winston, Takahiro Ito, Vatche G. Agopian, Fady M. Kaldas
Publikováno v:
Transplantation. 105:586-592
BACKGROUND Patients with end-stage liver disease and pretransplant Aspergillus colonization are problematic for determining liver transplant candidacy and timing of transplantation because of concerns for posttransplant invasive aspergillosis. METHOD
Autor:
Nina Singh, Drew J. Winston, G. Marshall Lyon, Raymund R. Razonable, Marilyn M. Wagener, Ajit P. Limaye, Fernanda P. Silveira
Publikováno v:
J Infect Dis
Background Detailed cytomegalovirus (CMV) kinetics in donor CMV-seropositive, recipient CMV-seronegative (D+/R–) transplant recipients receiving preemptive therapy (PET) have not been fully defined. Methods The study population consisted of the PET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6aa95086a76a93e9112cd1f3f2625d
https://europepmc.org/articles/PMC8807231/
https://europepmc.org/articles/PMC8807231/
Autor:
Oladunni Adeyiga, Susan Realegeno, Omer E. Beaird, Omai B. Garner, Shangxin Yang, Drew J. Winston
Publikováno v:
IDCases, Vol 26, Iss, Pp e01308-(2021)
IDCases
IDCases
A 44-year-old woman undergoing therapy for acute promyelocytic leukemia (APL) developed disseminated tuberculosis. Mycobacterium tuberculosis (TB) was isolated from the blood and sputum. Initial drug susceptibility testing (DST) of the blood isolate
Autor:
Nina Singh, Ajit P. Limaye, Marilyn M. Wagener, Raymund R. Razonable, G. Marshall Lyon, Fernanda P. Silveira, Drew J. Winston
Publikováno v:
J Infect Dis
Background The risk factors for development of viremia in high-risk donor cytomegalovirus (CMV)-seropositive and recipient CMV-seronegative (D+R−) transplant recipients are incompletely defined. Methods The study population comprised patients in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fe51cf82320028cca524122ff4fe133
https://europepmc.org/articles/PMC8006424/
https://europepmc.org/articles/PMC8006424/
Autor:
Zoran Popmihajlov, Michael Boeckh, Lei Pang, Drew J. Winston, Kimberly Hurtado, Vicki A. Morrison, Luis H. Camacho, Jessie Durrand Hall, Shu-Chih Su, Kathleen M. Mullane, Ann M. Arvin, Paula W. Annunziato, Susan S. Kaplan
Publikováno v:
Open Forum Infectious Diseases
Background In phase 3 trials, inactivated varicella zoster virus (VZV) vaccine (ZVIN) was well tolerated and efficacious against herpes zoster (HZ) in autologous hematopoietic stem cell transplant (auto-HSCT) recipients and patients with solid tumor
Autor:
Arpit, Amin, Alfonso, Molina, Lisa, Quach, Takahiro, Ito, Robert, McMillan, Joseph, DiNorcia, Vatche G, Agopian, Fady M, Kaldas, Douglas G, Farmer, Ronald W, Busuttil, Drew J, Winston
Publikováno v:
Transplantation. 105(3)
Patients with end-stage liver disease and pretransplant Aspergillus colonization are problematic for determining liver transplant candidacy and timing of transplantation because of concerns for posttransplant invasive aspergillosis.We performed a ret